Madame Bioscience PCL (BKK:MADAME)
Thailand · Delayed Price · Currency is THB 0.1300
+0.0100 (8.33%)
At close: Feb 5, 2026
Madame Bioscience PCL Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -6.41 | -332.04 | -405.81 | -422.31 | -152.43 | -58.71 |
Depreciation & Amortization | 68.78 | 91.11 | 107.02 | 90.33 | 93.68 | 105.6 |
Other Amortization | 0.81 | 0.81 | 0.81 | 1.65 | 1.87 | 0.89 |
Loss (Gain) From Sale of Assets | 6.07 | 2.7 | -0.31 | 22.69 | -14.46 | 0.09 |
Asset Writedown & Restructuring Costs | 15.91 | -1.16 | 198.82 | 26.99 | 127.86 | 25.01 |
Loss (Gain) From Sale of Investments | -98.01 | - | - | - | - | 0.22 |
Provision & Write-off of Bad Debts | 0.74 | 0.13 | -0.09 | -1.82 | 2.54 | -0.25 |
Other Operating Activities | 17.31 | 377.47 | 53.4 | 44.07 | -19.27 | 7.44 |
Change in Accounts Receivable | 139.3 | -4.34 | -28.24 | 74.36 | -76.52 | -41.58 |
Change in Inventory | 95.67 | 72.63 | 50.92 | 95.04 | -122.61 | -92.95 |
Change in Accounts Payable | -151.94 | 13.64 | 71.79 | -79.54 | 139.08 | 28.61 |
Change in Other Net Operating Assets | -13.46 | 6.06 | 23.68 | -16.12 | -77.85 | -26.32 |
Operating Cash Flow | 74.78 | 227.01 | 71.98 | -163.44 | -98.48 | -51.84 |
Operating Cash Flow Growth | -53.96% | 215.36% | - | - | - | - |
Capital Expenditures | -13.83 | -15.39 | -39.61 | -144.02 | -206.38 | -142.46 |
Sale of Property, Plant & Equipment | 2.04 | 1.41 | 6.74 | 0.17 | 1.41 | 0.04 |
Cash Acquisitions | -160.46 | - | - | -484.08 | - | - |
Divestitures | - | - | - | - | 84.43 | - |
Investment in Securities | - | - | - | - | - | 9 |
Other Investing Activities | 13.03 | 1.73 | -84.9 | -27.78 | - | -3.3 |
Investing Cash Flow | -159.22 | -12.25 | -117.77 | -655.71 | -120.53 | -136.72 |
Short-Term Debt Issued | - | - | - | 58.43 | 628.62 | 365.37 |
Long-Term Debt Issued | - | 9.89 | - | 386.11 | 135.08 | 18.84 |
Total Debt Issued | 56.45 | 9.89 | - | 444.54 | 763.7 | 384.22 |
Short-Term Debt Repaid | - | -1.96 | -34.86 | - | -598.89 | -348.37 |
Long-Term Debt Repaid | - | -205.73 | -83.49 | -21.77 | -47.33 | -23.5 |
Total Debt Repaid | -21.65 | -207.69 | -118.36 | -21.77 | -646.22 | -371.87 |
Net Debt Issued (Repaid) | 34.8 | -197.8 | -118.36 | 422.76 | 117.48 | 12.35 |
Issuance of Common Stock | 189.99 | 73.83 | - | 646.27 | 103.28 | 6.83 |
Other Financing Activities | 147.81 | -44.94 | -54.22 | -38.45 | -60.31 | 24.33 |
Financing Cash Flow | 372.6 | -168.9 | -172.57 | 1,031 | 160.45 | 43.5 |
Net Cash Flow | 288.15 | 45.85 | -218.35 | 211.43 | -58.56 | -145.06 |
Free Cash Flow | 60.95 | 211.62 | 32.37 | -307.46 | -304.86 | -194.31 |
Free Cash Flow Growth | -57.64% | 553.65% | - | - | - | - |
Free Cash Flow Margin | 3.78% | 9.97% | 1.41% | -13.80% | -16.37% | -12.81% |
Free Cash Flow Per Share | 0.02 | 0.07 | 0.01 | -0.10 | -0.15 | -0.10 |
Cash Interest Paid | 26.22 | 44.94 | 54.22 | 38.45 | 10.31 | 10.22 |
Cash Income Tax Paid | 3.12 | 1.15 | 0.83 | 14.46 | 3.98 | 1.48 |
Levered Free Cash Flow | 313.7 | 184.72 | 50.55 | -216.02 | -315.95 | -198.31 |
Unlevered Free Cash Flow | 336.64 | 216.56 | 88.74 | -189.69 | -309.35 | -192.7 |
Change in Working Capital | 69.58 | 87.98 | 118.15 | 73.73 | -137.9 | -132.24 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.